|
2024
|
Invention
|
Use of dextran sulfate.
A method for treating or inhibiting a neurological disease, disorder or ... |
|
2022
|
Invention
|
Method for dissolving scars with dextran sulfate. A method for dissolving scars comprises adminis... |
|
|
Invention
|
Treatment of virus infections.
The invention relates to dextran sulfate, or a pharmaceutically a... |
|
|
Invention
|
Treatment of virus infections. The invention relates to dextran sulfate, or a pharmaceutically ac... |
|
|
Invention
|
Combination for treatment of thromboinflammation.
The invention relates to a combination compris... |
|
|
Invention
|
Combination for treatment of thromboinflammation. The invention relates to a combination comprisi... |
|
2021
|
Invention
|
Treatment of muscle atrophy using dextran sulfate.
The present invention relates to the use of d... |
|
|
Invention
|
Treatment of muscle atrophy using dextran sulfate. The present invention relates to the use of de... |
|
|
Invention
|
Treatment of fatty liver diseases.
The invention relates to dextran sulfate, or a pharmaceutical... |
|
|
Invention
|
Treatment of fatty liver diseases. The invention relates to dextran sulfate, or a pharmaceuticall... |
|
|
Invention
|
Treatment of coronavirus infections.
The invention relates to dextran sulfate, or a pharmaceutic... |
|
|
Invention
|
Treatment of sepsis and hypercytokinemia. The invention relates to dextran sulfate, or a pharmace... |
|
|
Invention
|
Treatment of coronavirus infections. The invention relates to dextran sulfate, or a pharmaceutica... |
|
2020
|
Invention
|
Allogenic car-t cell therapy.
The invention relates to the use of dextran sulfate, or a pharmace... |
|
|
Invention
|
Allogenic car-t cell therapy. The invention relates to the use of dextran sulfate, or a pharmaceu... |
|
|
Invention
|
Treatment efficiency evaluation.
The efficiency of dextran sulfate treatment is determined based... |
|
|
Invention
|
Treatment efficiency evaluation. The efficiency of dextran sulfate treatment is determined based ... |
|
2019
|
Invention
|
Use of dextran sulfate. The present embodiments relate to the use of dextran sulfate having an av... |
|
|
Invention
|
Dextran sulfate. n) as measured by nuclear magnetic resonance (NMR) spectroscopy within an interv... |
|
2018
|
Invention
|
Use of dextran sulfate. Dextran sulfate, or a pharmaceutically acceptable derivative thereof, is ... |
|
|
Invention
|
Dextran sulfate for use in the treatment of neurological conditions. Dextran sulfate, or a pharma... |
|
|
Invention
|
New use of dextran sulfate. Dextran sulfate, or a pharmaceutically acceptable derivative thereof,... |
|
|
Invention
|
Treatment of glaucoma. The present embodiments generally relate to dextran sulfate, or a pharmace... |
|
2016
|
Invention
|
Use of dextran sulfate. The present embodiments relate to the use of dextran sulfate formulated f... |
|
|
Invention
|
New use of dextran sulfate. The present embodiments relate to the use of dextran sulfate formulat... |
|
|
Invention
|
Use of dextran sulfate. A graft composition intended for transplantation into a human patient com... |
|
2015
|
Invention
|
Dextran sulfate. A dextran sulfate, or a salt thereof, has a number average molecular weight (Mn)... |
|
|
Invention
|
New dextran sulfate. A dextran sulfate, or a salt thereof, has a number average molecular weight ... |
|
|
Invention
|
Use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenesi... |
|
|
Invention
|
The use of dextran sulfate having an average molecular weight below 10000 da for inducing angioge... |
|
2014
|
Invention
|
Dextran sulfate for use in mobilization of cells. Dextran sulfate in a range of 3500 and 9500 Da ... |
|
2013
|
Invention
|
Use of dextran sulfate. A graft composition intended for transplantation into a patient comprises... |
|
|
Invention
|
Use of dextran sulfate. A method of inhibiting Instant Blood-Mediated Inflammatory Reaction (IBMI... |
|
2011
|
Invention
|
Methods for reducing pulmonary uptake of intravenously injected cells. Dextran sulfate is used in... |
|
|
Invention
|
Cell therapy. Dextran sulfate is used in order to reduce pulmonary uptake of intravenously inject... |
|
2010
|
Invention
|
Method of treating graft-rejection using dextran sulfate. The present invention refers to use of ... |
|
2007
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
2003
|
Invention
|
Use of dextran sulfate. The present invention refers to use of dextran sulfate, or a pharmaceutic... |
|
|
Invention
|
Use of dextran sulfate in the treatment of instant blood-mediated inflammatory reaction.
|
